CM
Crestline Management’s Sana Biotechnology SANA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.61M | Sell |
2,420,937
-370,000
| -13% | -$1.01M | 10.56% | 2 |
|
|
2025
Q1 | $4.69M | Sell |
2,790,937
-70,000
| -2% | -$118K | 7.41% | 2 |
|
|
2024
Q4 | $4.66M | Sell |
2,860,937
-224,687
| -7% | -$366K | 0.16% | 147 |
|
|
2024
Q3 | $12.8M | Sell |
3,085,624
-140,000
| -4% | -$582K | 0.67% | 23 |
|
|
2024
Q2 | $17.6M | Sell |
3,225,624
-140,000
| -4% | -$764K | 1.37% | 8 |
|
|
2024
Q1 | $33.7M | Hold |
3,365,624
| – | – | 2.97% | 2 |
|
|
2023
Q4 | $13.7M | Hold |
3,365,624
| – | – | 1.17% | 13 |
|
|
2023
Q3 | $13M | Hold |
3,365,624
| – | – | 1.52% | 7 |
|
|
2023
Q2 | $20.1M | Buy |
3,365,624
+154,687
| +5% | +$922K | 2.09% | 2 |
|
|
2023
Q1 | $10.5M | Sell |
3,210,937
-154,687
| -5% | -$506K | 1.25% | 14 |
|
|
2022
Q4 | $13.3M | Hold |
3,365,624
| – | – | 1.95% | 4 |
|
|
2022
Q3 | $20.2M | Hold |
3,365,624
| – | – | 2.73% | 2 |
|
|
2022
Q2 | $21.6M | Buy |
3,365,624
+154,687
| +5% | +$995K | 2.82% | 2 |
|
|
2022
Q1 | $26.5M | Hold |
3,210,937
| – | – | 3.18% | 2 |
|
|
2021
Q4 | $49.7M | Hold |
3,210,937
| – | – | 3.71% | 6 |
|
|
2021
Q3 | $72.3M | Hold |
3,210,937
| – | – | 6.8% | 2 |
|
|
2021
Q2 | $63.1M | Buy |
+3,210,937
| New | +$63.1M | 5.44% | 2 |
|